nodes	percent_of_prediction	percent_of_DWPC	metapath
Tofisopam—PDE2A—Nitric oxide stimulates guanylate cyclase—GUCY1A3—salivary gland cancer	0.172	0.172	CbGpPWpGaD
Tofisopam—PDE10A—Nitric oxide stimulates guanylate cyclase—GUCY1A3—salivary gland cancer	0.13	0.13	CbGpPWpGaD
Tofisopam—PDE3A—Nitric oxide stimulates guanylate cyclase—GUCY1A3—salivary gland cancer	0.0767	0.0767	CbGpPWpGaD
Tofisopam—PDE2A—Platelet homeostasis—GUCY1A3—salivary gland cancer	0.0668	0.0668	CbGpPWpGaD
Tofisopam—PDE10A—Platelet homeostasis—GUCY1A3—salivary gland cancer	0.0507	0.0507	CbGpPWpGaD
Tofisopam—PDE2A—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0376	0.0376	CbGpPWpGaD
Tofisopam—PDE3A—Platelet homeostasis—GUCY1A3—salivary gland cancer	0.0299	0.0299	CbGpPWpGaD
Tofisopam—PDE10A—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0285	0.0285	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—JMJD1C—salivary gland cancer	0.0232	0.0232	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—JMJD1C—salivary gland cancer	0.0176	0.0176	CbGpPWpGaD
Tofisopam—PDE4A—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0173	0.0173	CbGpPWpGaD
Tofisopam—PDE3A—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0168	0.0168	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—GUCY1A3—salivary gland cancer	0.015	0.015	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—GAS6—salivary gland cancer	0.015	0.015	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—GUCY1A3—salivary gland cancer	0.0114	0.0114	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—GAS6—salivary gland cancer	0.0114	0.0114	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—JMJD1C—salivary gland cancer	0.0104	0.0104	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—MYB—salivary gland cancer	0.00891	0.00891	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00788	0.00788	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00772	0.00772	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MC3R—salivary gland cancer	0.00701	0.00701	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—MYB—salivary gland cancer	0.00675	0.00675	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—GAS6—salivary gland cancer	0.00669	0.00669	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—GUCY1A3—salivary gland cancer	0.00669	0.00669	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00597	0.00597	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00585	0.00585	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MC3R—salivary gland cancer	0.00531	0.00531	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—WNT5B—salivary gland cancer	0.00526	0.00526	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—IL17RD—salivary gland cancer	0.00508	0.00508	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAML3—salivary gland cancer	0.00464	0.00464	CbGpPWpGaD
Tofisopam—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00459	0.00459	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MC3R—salivary gland cancer	0.00414	0.00414	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00398	0.00398	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—WNT5B—salivary gland cancer	0.00398	0.00398	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—MYB—salivary gland cancer	0.00398	0.00398	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—IL17RD—salivary gland cancer	0.00385	0.00385	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—DTX4—salivary gland cancer	0.00362	0.00362	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00362	0.00362	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00354	0.00354	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00352	0.00352	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAML3—salivary gland cancer	0.00352	0.00352	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00345	0.00345	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—CREBBP—salivary gland cancer	0.00328	0.00328	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MC3R—salivary gland cancer	0.00322	0.00322	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MC3R—salivary gland cancer	0.00314	0.00314	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MC3R—salivary gland cancer	0.00313	0.00313	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00302	0.00302	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FGF16—salivary gland cancer	0.00299	0.00299	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—DTX4—salivary gland cancer	0.00274	0.00274	CbGpPWpGaD
Tofisopam—PDE4A—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00272	0.00272	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAML2—salivary gland cancer	0.0026	0.0026	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00254	0.00254	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—CREBBP—salivary gland cancer	0.00249	0.00249	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—WNT5B—salivary gland cancer	0.00241	0.00241	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—WNT5B—salivary gland cancer	0.00235	0.00235	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—IL17RD—salivary gland cancer	0.00233	0.00233	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FGF16—salivary gland cancer	0.00227	0.00227	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—IL17RD—salivary gland cancer	0.00227	0.00227	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—EP300—salivary gland cancer	0.00223	0.00223	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—JAG1—salivary gland cancer	0.00222	0.00222	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FGFR4—salivary gland cancer	0.00221	0.00221	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FBXW7—salivary gland cancer	0.00217	0.00217	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAML3—salivary gland cancer	0.00213	0.00213	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAML3—salivary gland cancer	0.00207	0.00207	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAML2—salivary gland cancer	0.00197	0.00197	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00192	0.00192	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MC3R—salivary gland cancer	0.0019	0.0019	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MC3R—salivary gland cancer	0.00185	0.00185	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—FOXO3—salivary gland cancer	0.00183	0.00183	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00183	0.00183	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00178	0.00178	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—EP300—salivary gland cancer	0.00169	0.00169	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—JAG1—salivary gland cancer	0.00168	0.00168	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FGFR4—salivary gland cancer	0.00167	0.00167	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—DTX4—salivary gland cancer	0.00166	0.00166	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—PIK3CA—salivary gland cancer	0.00165	0.00165	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FBXW7—salivary gland cancer	0.00165	0.00165	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—DTX4—salivary gland cancer	0.00162	0.00162	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—TP53—salivary gland cancer	0.0016	0.0016	CbGpPWpGaD
Tofisopam—PDE2A—Hemostasis—HRAS—salivary gland cancer	0.00153	0.00153	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—MAP2K2—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—CREBBP—salivary gland cancer	0.00147	0.00147	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—FOXO3—salivary gland cancer	0.00139	0.00139	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FGF16—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGF16—salivary gland cancer	0.00134	0.00134	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—PIK3CA—salivary gland cancer	0.00125	0.00125	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—NOTCH1—salivary gland cancer	0.00123	0.00123	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—TP53—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAML2—salivary gland cancer	0.00119	0.00119	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00116	0.00116	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAML2—salivary gland cancer	0.00116	0.00116	CbGpPWpGaD
Tofisopam—PDE10A—Hemostasis—HRAS—salivary gland cancer	0.00116	0.00116	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—MAP2K2—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CREBBP—salivary gland cancer	0.00111	0.00111	CbGpPWpGaD
Tofisopam—PDE2A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—JAG1—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FGFR4—salivary gland cancer	0.00101	0.00101	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FBXW7—salivary gland cancer	0.000998	0.000998	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—EP300—salivary gland cancer	0.000998	0.000998	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—JAG1—salivary gland cancer	0.000991	0.000991	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FGFR4—salivary gland cancer	0.000987	0.000987	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FBXW7—salivary gland cancer	0.000971	0.000971	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000949	0.000949	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—NOTCH1—salivary gland cancer	0.00093	0.00093	CbGpPWpGaD
Tofisopam—PDE2A—Signaling by GPCR—HRAS—salivary gland cancer	0.000878	0.000878	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CREBBP—salivary gland cancer	0.000843	0.000843	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—FOXO3—salivary gland cancer	0.000842	0.000842	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—CCND1—salivary gland cancer	0.000823	0.000823	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—FOXO3—salivary gland cancer	0.000819	0.000819	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PTEN—salivary gland cancer	0.000795	0.000795	CbGpPWpGaD
Tofisopam—PDE10A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000792	0.000792	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—EP300—salivary gland cancer	0.000758	0.000758	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—PIK3CA—salivary gland cancer	0.000738	0.000738	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000719	0.000719	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—TP53—salivary gland cancer	0.000714	0.000714	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000688	0.000688	CbGpPWpGaD
Tofisopam—PDE3A—Hemostasis—HRAS—salivary gland cancer	0.000683	0.000683	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000669	0.000669	CbGpPWpGaD
Tofisopam—PDE10A—Signaling by GPCR—HRAS—salivary gland cancer	0.000665	0.000665	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—CCND1—salivary gland cancer	0.000624	0.000624	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PTEN—salivary gland cancer	0.000602	0.000602	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—EP300—salivary gland cancer	0.000574	0.000574	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.00057	0.00057	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000563	0.000563	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000561	0.000561	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000548	0.000548	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—TP53—salivary gland cancer	0.000542	0.000542	CbGpPWpGaD
Tofisopam—PDE2A—Signaling Pathways—HRAS—salivary gland cancer	0.000519	0.000519	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CREBBP—salivary gland cancer	0.000511	0.000511	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CREBBP—salivary gland cancer	0.000497	0.000497	CbGpPWpGaD
Tofisopam—PDE4A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00048	0.00048	CbGpPWpGaD
Tofisopam—PDE3A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000467	0.000467	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000464	0.000464	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000436	0.000436	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000432	0.000432	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000425	0.000425	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000424	0.000424	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—TP53—salivary gland cancer	0.000411	0.000411	CbGpPWpGaD
Tofisopam—PDE4A—Signaling by GPCR—HRAS—salivary gland cancer	0.000403	0.000403	CbGpPWpGaD
Tofisopam—PDE10A—Signaling Pathways—HRAS—salivary gland cancer	0.000393	0.000393	CbGpPWpGaD
Tofisopam—PDE3A—Signaling by GPCR—HRAS—salivary gland cancer	0.000392	0.000392	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—CCND1—salivary gland cancer	0.000378	0.000378	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—CCND1—salivary gland cancer	0.000368	0.000368	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PTEN—salivary gland cancer	0.000365	0.000365	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PTEN—salivary gland cancer	0.000355	0.000355	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000352	0.000352	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—EP300—salivary gland cancer	0.000348	0.000348	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000339	0.000339	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—EP300—salivary gland cancer	0.000338	0.000338	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000308	0.000308	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000257	0.000257	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—PIK3CA—salivary gland cancer	0.00025	0.00025	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—TP53—salivary gland cancer	0.000249	0.000249	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000244	0.000244	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—TP53—salivary gland cancer	0.000242	0.000242	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000242	0.000242	CbGpPWpGaD
Tofisopam—PDE4A—Signaling Pathways—HRAS—salivary gland cancer	0.000238	0.000238	CbGpPWpGaD
Tofisopam—PDE3A—Signaling Pathways—HRAS—salivary gland cancer	0.000232	0.000232	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—CREBBP—salivary gland cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PTEN—salivary gland cancer	6.76e-05	6.76e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—EP300—salivary gland cancer	6.44e-05	6.44e-05	CbGpPWpGaD
Tofisopam—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	4.77e-05	4.77e-05	CbGpPWpGaD
